Previous 10 | Next 10 |
2023-11-12 08:36:13 ET Summary Lantheus experienced tremendous growth in the last two years thanks to the approval of a new imaging agent called PYLARIFY. The company now faces several catalysts including the approval of PYLARIFY in Europe and the commercialization of PNT2002 and ...
2023-11-03 06:10:25 ET Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Conference Call November 02, 2023, 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - Chief Executive Officer Paul Blanchfield - President ...
2023-11-02 07:09:05 ET More on Lantheus Lantheus: Fast-Growing Radiotherapeutics Specialist Can Benefit From Lilly's POINT Biopharma Takeover Lantheus: Growth Well Priced In, Profitability Next Hurdle (Rating Downgrade) Lantheus: Not Quite Ready To Take The Plunge ...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Worldwide revenue of $319.9 million for the third quarter 2023, representing an increase of 33.7% from the prior year period GAAP net income of $132.0 million for the third quarter 2023, compared to GAAP net income of $61.2 million in the prior year period GAAP fully diluted net i...
Lantheus Holdings Inc. (LNTH) is expected to report $1.19 for Q3 2023
2023-11-01 13:02:03 ET More on Lantheus Lantheus: Fast-Growing Radiotherapeutics Specialist Can Benefit From Lilly's POINT Biopharma Takeover Lantheus: Growth Well Priced In, Profitability Next Hurdle (Rating Downgrade) Lantheus: Not Quite Ready To Take The Plunge ...
BEDFORD, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 2, 2023, to discuss its financial and operating results for the third qu...
2023-10-12 16:35:30 ET Summary Lantheus Holdings' stock price has increased more than 1000% since its IPO in 2015, with most gains occurring since 2022. The success of its product PYLARIFY, a PSMA-targeted PET imaging agent for prostate cancer, has driven significant revenue growt...
2023-10-03 08:41:53 ET Gainers: Alx Oncology ( ALXO ) +116% . Vericity ( VERY ) +95% Strengthens Individual Insurance Presence in the United States with the Acquisition of Vericity. POINT Biopharma Global ( PNT ) +85% to acquire Point ...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...